Stocks Explorer
Stocks
Sectors
Search
Cybin Inc.(CYBN) News
Profile
Chart
News
Analysis
Holders
CYBN price today
by TradingView
Date
Title
Nov 30
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
‹ Prev
Page
of 2
Next ›